Movement

Ekelund harmonised data from 1,005,791 adults across 16 studies and found that 8 or more hours of daily sitting with no physical activity increased all-cause mortality by 59% compared to the least sedentary quartile. However, 60 to 75 minutes of moderate-intensity physical activity per day completely attenuated the excess risk, even among those sitting 8 or more hours.

The dose-response curve revealed that high television viewing time (5+ hours daily) retained a 16% elevated mortality risk even among the most active participants, suggesting screen-based sitting may carry additional risk beyond simple sedentary time. The finding that activity eliminates sitting risk is more clinically useful than the finding that sitting increases risk. The prescription is specific: one hour of movement per day, every day.

Virtanen et al. (2009, NEJM) used PET-CT to demonstrate that cold exposure activates brown adipose tissue (BAT) in adult humans, increasing BAT metabolic rate by 350 per cent. Participants exposed to 19°C for two hours showed significant glucose uptake in supraclavicular and paravertebral BAT depots. The discovery overturned the longstanding assumption that functional BAT was limited to infants.

This is because brown adipocytes contain dense mitochondria with uncoupling protein 1 (UCP1), which short-circuits the electron transport chain to generate heat instead of ATP. Cold activates the sympathetic nervous system, releasing norepinephrine that binds beta-3 adrenergic receptors on BAT cells, triggering lipolysis and thermogenesis. Regular cold exposure increases BAT volume through recruitment of "beige" adipocytes from white fat depots (Yoneshiro et al., 2013, Journal of Clinical Investigation).

Lee et al. (2014, Diabetes) showed that one month of sleeping in a 19°C room increased BAT volume by 42 per cent, improved insulin sensitivity and increased energy expenditure. Conversely, one month at 27°C reversed these gains. Modern thermoneutral environments (centrally heated homes, offices, cars) have eliminated the mild cold stress that humans experienced throughout evolutionary history. The loss of cold exposure is a loss of metabolic stimulus.

Skeletal muscle mass declines at 3 to 8% per decade after age 30, accelerating markedly after 60. Cruz-Jentoft defined sarcopenia as the age-associated loss of muscle mass, strength and physical performance and estimated prevalence at 5 to 13% in adults aged 60 to 70, rising to 11 to 50% in those over 80. In the UK, the condition is substantially underdiagnosed and rarely managed proactively.

Sarcopenia increases fall risk, fracture risk, hospitalisation and mortality. The primary driver is disuse: sedentary lifestyles accelerate muscle loss beyond what ageing alone would produce. Resistance exercise is the only intervention with consistent evidence of reversal. Protein intake above 1.2 grams per kilogram body weight per day is required to maintain synthesis rates. The modern combination of physical inactivity and protein-diluted ultra-processed diets accelerates muscle loss from both directions.

Mandsager analysed 122,007 patients who underwent cardiopulmonary exercise testing between 1991 and 2014 and tracked all-cause mortality over a median 8.4-year follow-up. The lowest-fitness quintile had 5 times the mortality of the elite fitness group. The dose-response curve showed no upper threshold: extreme fitness was associated with the lowest mortality, contradicting the "too much exercise" narrative.

The relationship was stronger than smoking, diabetes, or coronary artery disease as a predictor of death. Each 1-MET improvement in cardiorespiratory fitness reduced mortality risk by approximately twelve percent. VO2 max integrates cardiovascular, pulmonary, muscular and mitochondrial function into a single measurable value. It is the closest existing metric to a biological age.

Ghaly and Teplitz (2004) conducted a controlled study in which twelve participants slept grounded (connected to the Earth’s surface via a conductive sheet) for eight weeks. Salivary cortisol profiles were measured before and after. Grounded subjects showed a 31 per cent reduction in night-time cortisol, with cortisol rhythms shifting toward normal circadian alignment: higher morning peaks and lower nocturnal troughs. Ungrounded controls showed no change.

This is because the Earth’s surface carries a negative electrical potential maintained by the global atmospheric electrical circuit. Direct skin contact with the ground allows free electrons to flow into the body, neutralising reactive oxygen species and reducing chronic inflammatory signalling. Oschman et al. (2015) reviewed the biophysics and documented that grounding reduces blood viscosity (Chevalier et al. 2013), improves heart rate variability and accelerates wound healing by reducing the inflammatory response at the site of injury.

For most of human history, humans slept on the ground, walked barefoot and maintained continuous electrical contact with the Earth. Modern insulating materials (rubber-soled shoes, synthetic flooring, elevated beds) have severed this connection entirely within two generations. The body accumulates positive charge from electronic devices and synthetic environments, contributing to chronic inflammation that grounding directly and measurably reverses.

Sport England Active Lives data shows 25.2% of UK adults, approximately 12.3 million people, are physically inactive, defined as fewer than 30 minutes of moderate activity per week. A further 25.7% are insufficiently active, falling below the 150-minute weekly guideline. Physical inactivity costs the NHS and social care system an estimated £7.4 billion per year in direct treatment of attributable disease.

The figure has barely changed in a decade despite multiple government strategies and campaigns. The built environment, sedentary work, car dependency and screen-based leisure structurally discourage movement. Physical activity is treated as a personal choice rather than an environmental condition. The same 19-year-old in Birmingham living in a high-rise with no green space and a desk job faces structural barriers that no motivational poster will overcome.

Ekelund et al. (2016), in a harmonised meta-analysis of 16 studies totalling over one million adults published in The Lancet, found that sitting for more than 8 hours per day with low physical activity was associated with a 49 per cent increase in all-cause mortality compared to the lowest sitting/highest activity group. Crucially, 60 to 75 minutes of moderate-intensity physical activity per day eliminated the excess mortality associated with high sitting time, but only 25 per cent of participants achieved this threshold.

This is because prolonged sitting suppresses lipoprotein lipase activity in skeletal muscle, reducing triglyceride clearance by up to 90 per cent within hours. Insulin sensitivity drops measurably after a single day of sitting. Femoral artery blood flow reduces, impairing endothelial function. These are not adaptations to inactivity: they are acute physiological responses to the absence of the low-grade muscular contractions (postural shifts, walking, squatting, carrying) that characterised human movement patterns for millions of years.

The modern office worker sits for approximately 9.3 hours per day (Healy et al. 2011). This exceeds the 8-hour threshold associated with a 49 per cent mortality increase. The response from public health has been to recommend "150 minutes of moderate exercise per week," which is roughly 21 minutes per day. The evidence shows this is insufficient to offset 9 hours of sitting. The problem is not that people fail to exercise. The problem is that the built environment was redesigned to eliminate the continuous low-level movement that human physiology requires.

Bey and Hamilton (2003, Journal of Physiology) demonstrated that lipoprotein lipase (LPL) activity in rat hindlimb muscles fell by 90% within hours of inactivity. Hamilton et al. (2007, Diabetes) confirmed in human studies that prolonged sitting suppressed LPL independent of exercise habits: a person who runs 5km in the morning then sits for 8 hours has the same LPL suppression as a sedentary person. Standing or slow walking maintains LPL activity at 50 to 75% of peak.

This is because LPL is anchored to capillary endothelial cells in skeletal muscle and requires local contractile activity for mRNA expression and enzyme translocation. Sitting eliminates the low-grade postural contractions of the legs and trunk that maintain LPL above basal levels. Without LPL, circulating triglycerides cannot be hydrolysed for muscular uptake and remain elevated in plasma, driving insulin resistance, VLDL accumulation and adipose deposition.

The metabolic cost of sitting is not the absence of exercise calories. It is the enzymatic shutdown that reroutes dietary fat from muscle oxidation to adipose storage. Dunstan et al. (2012, Diabetes Care) showed that breaking sitting time every 20 minutes with 2 minutes of light walking reduced postprandial glucose by 24% and insulin by 23%. The intervention is trivially simple. The barrier is architectural: offices, cars and screens are designed for immobility.

The National Travel Survey shows a twenty-seven per cent fall in walking trips per person in Great Britain over the two decades from 1996 to 2016, with the steepest declines in utility walking for school, work and shopping.

Walking is the most fundamental human movement pattern and provides a metabolic stimulus quite distinct from structured exercise. The loss of ambient daily movement, independent of any gym attendance, is now recognised as a distinct risk factor for metabolic disease.

The decline reflects changes in land use, car dependency and the gradual erosion of walkable communities, most of which were built before the era of mass car ownership and have been progressively redesigned around vehicle access.

The Prospective Urban Rural Epidemiology study measured grip strength in 139,691 adults across 17 countries and tracked outcomes over four years. Each 5-kilogram reduction in grip strength predicted 16% higher all-cause mortality, 17% higher cardiovascular mortality and 7% higher risk of myocardial infarction. Grip strength was a stronger predictor of death than systolic blood pressure.

Grip strength serves as a proxy for total body muscle mass, neurological function and nutritional status. It declines with age, inactivity, malnutrition and chronic disease. The measurement takes 30 seconds using a handheld dynamometer costing under fifty pounds. Despite its predictive power exceeding most blood tests, it is not routinely measured in any NHS health assessment.

Leong et al. (2015) in The Lancet analysed 139,691 adults across 17 countries in the Prospective Urban Rural Epidemiology (PURE) study and found that each 5 kg decrease in grip strength was associated with a 16 per cent increase in all-cause mortality (HR 1.16, 95% CI 1.13 to 1.20), a 17 per cent increase in cardiovascular mortality and a 7 per cent increase in myocardial infarction risk. Grip strength was a stronger predictor of all-cause mortality than systolic blood pressure in the same cohort.

This is because grip strength is a proxy measurement for total skeletal muscle mass and neuromuscular function. It reflects the cumulative effect of physical activity, nutrition, hormonal status (testosterone, growth hormone, IGF-1), inflammatory burden and nervous system integrity. A strong grip requires not just hand muscle strength but intact neural drive from the motor cortex, healthy motor neurons, functional neuromuscular junctions and adequate muscle protein synthesis. Declining grip strength signals systemic physiological deterioration before any single organ system shows clinical disease.

Despite being a stronger mortality predictor than blood pressure, grip strength is not measured in any routine health screening in the UK. Blood pressure is measured at every GP visit. Cholesterol is measured annually. Grip strength, which outperforms both as a mortality predictor, is measured in research settings only. The clinical infrastructure is designed to identify pharmaceutical treatment targets (hypertension, hyperlipidaemia), not functional capacity markers that would point toward movement, nutrition and lifestyle as interventions.

Robbins and Hanna (1987) documented that the human foot sole contains approximately 200,000 nerve endings, making it one of the most densely innervated surfaces in the body, comparable to the fingertips and lips. These mechanoreceptors (Meissner's corpuscles, Pacinian corpuscles, Ruffini endings, Merkel cells) provide continuous proprioceptive feedback about terrain, balance and load distribution. Subsequent research by Robbins et al. (1995) found that modern athletic shoes reduced balance and proprioceptive acuity by up to 70 per cent in elderly subjects compared to barefoot conditions.

This is because cushioned, elevated-heel shoes create a sensory deprivation chamber around the foot. The thick sole blocks texture, temperature and pressure signals. The elevated heel shifts the centre of gravity forward, altering the entire kinetic chain from ankle to spine. The narrow toe box compresses the forefoot, weakening intrinsic foot muscles and deforming the first metatarsophalangeal joint (bunions affect 23 per cent of adults aged 18 to 65 according to Nix et al. 2010). The rigid arch support prevents the foot's natural elastic arch from loading and recoiling, causing intrinsic muscle atrophy.

The consequences extend beyond foot health. The foot is the foundation of the human biomechanical chain. Altered foot mechanics change ankle dorsiflexion, knee tracking, hip alignment and spinal loading. D'Aout et al. (2009) found that habitually barefoot populations had wider feet, more even plantar pressure distribution and significantly lower rates of flat foot compared to shod populations. The epidemic of plantar fasciitis, bunions, knee pain, hip replacements and lower back pain in modern populations is not inevitable ageing. It is the downstream consequence of encasing the body's most proprioceptively dense interface in a sensory-blocking cushioned box.